98%
921
2 minutes
20
The potassium-chloride co-transporter 2, KCC2, is a neuron-specific ion transporter that plays a multifunctional role in neuronal development. In mature neurons, KCC2 maintains a low enough intracellular chloride concentration essential for inhibitory neurotransmission. During recent years, pathogenic variants in the KCC2 encoding gene affecting the functionality or expression of the transporter protein have been described in several patients with epilepsy of infancy with migrating focal seizures (EIMFS), a devastating early-onset developmental and epileptic encephalopathy. In this study, we identified a novel recessively inherited c.692G>A, p. (R231H) variant in a patient diagnosed with severe and drug-resistant EIMFS and profound intellectual disability. The functionality of the variant was assessed by means of gramicidin-perforated patch-clamp experiments and ammonium flux assay, both of which indicated a significant reduction in chloride extrusion. Based on surface immunolabeling, the variant showed a reduction in membrane expression. These findings implicate pathogenicity of the variant that leads to impaired inhibitory neurotransmission, increasing probability for hyperexcitability and epileptogenesis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11039960 | PMC |
http://dx.doi.org/10.3389/fnmol.2024.1372662 | DOI Listing |
Epilepsy Behav
September 2025
Biohaven Pharmaceuticals, Inc., New Haven, CT, USA.
Background: KCNQ2 developmental and epileptic encephalopathy (KCNQ2-DEE) is a rare pediatric disorder characterized by seizures and neurodevelopmental impairments. Parent- and healthcare professional (HCP)-reported outcomes regarding the impacts of seizures and neurodevelopmental impairments may guide the design of clinically meaningful KCNQ2-DEE outcome measures.
Methods: Parents of children with KCNQ2-DEE (N = 53) and HCPs with KCNQ2-DEE expertise (N = 2) participated in qualitative interviews exploring signs, symptoms, and impacts of KCNQ2-DEE, and how varying KCNQ2-DEE phenotypes affect child development.
Bioengineering (Basel)
August 2025
Department of Computer Science, Hal Marcus College of Science & Engineering, University of West Florida, Pensacola, FL 32514, USA.
Neuromuscular hip dysplasia (NHD) is a common deformity in children with cerebral palsy (CP). Although some predictive factors of NHD are known, the prediction of NHD is in its infancy. We present a Clinical Decision Support System (CDSS) designed to calculate the probability of developing NHD in children with CP.
View Article and Find Full Text PDFCureus
July 2025
Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, CHN.
16p11.2 deletion syndrome is a group disorder associated with intellectual impairment, developmental delay, and autism spectrum disorder (ASD). Paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) is an extremely rare condition.
View Article and Find Full Text PDFOrphanet J Rare Dis
August 2025
Department of Neurology, Children's Hospital Affiliated to Suzhou University, No. 92, Zhong Nan Street, Suzhou Industrial Park, Suzhou, 215025, Jiangsu Province, China.
Objective: To summarize the clinical characteristics of a cohort of nine Chinese children with GNAO1 encephalopathy and analyze their genotypes.
Methods: A retrospective study was conducted on nine children diagnosed with GNAO1 encephalopathy at the Neurology Department of two children's hospitals between January 2019 and December 2022. Their clinical manifestations, genetic test results, cranial imaging, electroencephalography and treatment were summarized.
Transl Pediatr
July 2025
Department of Pediatric Neurology, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Background: Epilepsy is a prevalent chronic neurological disorder that affects individuals across all age groups. Genetic factors are believed to play a significant role in the etiology of epilepsy; however, epilepsy associated with mutations in the chloride voltage-gated channel 4 () gene is clinically rare.
Case Description: We report a 2-year and 4-month-old male patient who experienced cluster convulsions due to a heterozygous variant in the gene (NM_001830: c.